These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14534691)

  • 21. Prospective study on the recurrence/metastasis of stage II/III colorectal cancer and gastric cancer associated with occult neoplastic cells in lymph node sinuses: three-year interim results.
    Mukai M; Tajima T; Sato S; Ninomiya H; Wakui K; Komatsu N; Tsuchiya K; Nakasaki H; Makuuchi H
    Oncol Rep; 2006 Aug; 16(2):405-10. PubMed ID: 16820923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
    Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
    Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
    Yano H; Saito Y; Kirihara Y; Takashima J
    Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
    Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
    Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
    Miyamoto S; Endoh Y; Hasebe T; Ishii G; Kodama K; Goya M; Ono M; Saitoh N; Chiba T; Ochiai A
    Oncol Rep; 2004 Aug; 12(2):245-51. PubMed ID: 15254684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma.
    Meguerditchian AN; Bairati I; Lagacé R; Harel F; Kibrité A
    Am J Surg; 2005 Jun; 189(6):707-13. PubMed ID: 15910724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
    Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
    Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the recurrence/metastasis of stage I and II breast cancer without lymph node metastasis.
    Mukai M; Sato S; Kimura T; Komatsu N; Ninomiya H; Nakasaki H; Ogoshi K; Makuuchi H
    Oncol Rep; 2004 Oct; 12(4):745-8. PubMed ID: 15375494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
    Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
    Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological grade predicts survival time associated with recurrence after resection for colorectal cancer.
    Cho YB; Chun HK; Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2009; 56(94-95):1335-40. PubMed ID: 19950787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue factor expression and metastatic potential of colorectal cancer.
    Shigemori C; Wada H; Matsumoto K; Shiku H; Nakamura S; Suzuki H
    Thromb Haemost; 1998 Dec; 80(6):894-8. PubMed ID: 9869156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study.
    Adell G; Boeryd B; Frånlund B; Sjödahl R; Håkansson L
    Eur J Surg; 1996 Aug; 162(8):637-42. PubMed ID: 8891622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
    Arango D; Laiho P; Kokko A; Alhopuro P; Sammalkorpi H; Salovaara R; Nicorici D; Hautaniemi S; Alazzouzi H; Mecklin JP; Järvinen H; Hemminki A; Astola J; Schwartz S; Aaltonen LA
    Gastroenterology; 2005 Sep; 129(3):874-84. PubMed ID: 16143127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
    Yao HB; Wu AG; Chen YJ; Tang BH
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Criteria for predicting the recurrence and metastasis of stage I and II gastric cancer without lymph node metastasis.
    Mukai M; Sato S; Kimura T; Komatsu N; Ninomiya H; Nakasaki H; Ogoshi K; Makuuchi H
    Oncol Rep; 2004 Jul; 12(1):59-62. PubMed ID: 15201959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
    De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
    Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.